Disease management vendor Omada Health has secured yet another large round of financing, $73 million worth. Lot of hype around the new generation of disease management vendors, but I predict the same outcome in terms of value to patients and payers and returns to investors--not much.
A Transunion study indicates the patients are continuing to see a rise in the share of medical costs that they pay, particularly for inpatient services, as the average cost-share rose from around $4100 in 2017 to $4650 in 2018.
Patients Like Me apparently is also liked by UnitedHealth Group, as the uber-acquisitive firm is buying the creator of communities for patients with particular diseases. The patients' data is collected and sold to drug companies and others to generate revenue.
Spring Fertility plows fertile investing ground, getting an undisclosed amount of new capital to help people become pregnant. Gestation period for this investment was undisclosed but likely will be greater than nine months.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.